Cautreels Werner Insider Trades

Insider Trading History

Track insider trading activity for Cautreels Werner. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Traws Pharma
Traws Pharma TRAW
Director
Holding Value $46.3k 31,258 shares
Last Trade
Mar 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50k 31,258 shares
$1.60
$1.48
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Director
Holding Value $2.1k 31,258 shares
Last Trade
Mar 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.1k 31,258 shares
$0.07
$0.07
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Director
Holding Value $7.33k 109,222 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$327 4,874 shares
$0.07
$0.07
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Director
Holding Value $1.31k 19,496 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31k 19,496 shares
$0.07
$0.07
Traws Pharma
Traws Pharma TRAW
Director
Holding Value $162k 109,222 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 4,874 shares
$2.35
$1.48
Traws Pharma
Traws Pharma TRAW
Director
Holding Value $28.9k 19,496 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.4k 19,496 shares
$2.33
$1.48
Traws Pharma
Traws Pharma TRAW
Director
Holding Value $17.1k 11,530 shares
Last Trade
Oct 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.7k 11,530 shares
$3.01
$1.48
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Director
Holding Value $774 11,530 shares
Last Trade
Oct 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$774 11,530 shares
$0.07
$0.07
Traws Pharma
Traws Pharma TRAW
Director
Holding Value $34k 23,000 shares
Last Trade
Jun 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38k 23,000 shares
$1.65
$1.48
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Director
Holding Value $1.54k 23,000 shares
Last Trade
Jun 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.54k 23,000 shares
$0.07
$0.07
Traws Pharma
Traws Pharma TRAW
Chief Executive Officer
Holding Value $154k 104,348 shares
Last Trade
Feb 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$488k 96,348 shares
$5.06
$1.48
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.46k 96,348 shares
$0.07
$0.07
Traws Pharma
Traws Pharma TRAW
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$488k 96,348 shares
$5.06
$1.48
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Chief Executive Officer
Holding Value $7k 104,348 shares
Last Trade
Feb 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.46k 96,348 shares
$0.07
$0.07
Traws Pharma
Traws Pharma TRAW
Chief Executive Officer
Holding Value $143k 96,348 shares
Last Trade
Dec 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.29M 96,348 shares
$13.42
$1.48
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Chief Executive Officer
Holding Value $6.46k 96,348 shares
Last Trade
Dec 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.46k 96,348 shares
$0.07
$0.07
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Chief Executive Officer
Holding Value $6.46k 96,348 shares
Last Trade
Dec 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.46k 96,348 shares
$0.07
$0.07
Traws Pharma
Traws Pharma TRAW
Chief Executive Officer
Holding Value $143k 96,348 shares
Last Trade
Dec 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.29M 96,348 shares
$13.42
$1.48
Traws Pharma
Traws Pharma TRAW
Chief Executive Officer
Holding Value $296k 200,000 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 200,000 shares
$25.00
$1.48
Onconova Therapeutics- Warrants (01/08/2021)
Onconova Therapeutics- Warrants (01/08/2021) ONTXW
Chief Executive Officer
Holding Value $13.4k 200,000 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.4k 200,000 shares
$0.07
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up